Homology Medicines, Inc

(NASDAQ:FIXX)

Latest On Homology Medicines, Inc (FIXX):

Date/Time Type Description Signal Details
2023-05-11 19:45 ESTNewsHomology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21MN/A
2023-03-10 08:10 ESTNewsHomology Medicines GAAP EPS of -$0.60 misses by $0.07, revenue of $0.82M misses by $0.1MN/A
2023-03-09 16:37 ESTNewsHomology Medicines gets new chief medical officerN/A
2022-11-11 09:56 ESTNewsHomology Medicines GAAP EPS of -$0.59 misses by $0.11, revenue of $0.80M misses by $0.16MN/A
2022-09-07 01:48 ESTNewsHomology Medicines appoints new CEO, chairpersonN/A
2022-08-16 07:47 ESTNewsHomology Medicines GAAP EPS of -$0.51 beats by $0.04, revenue of $0.8M misses by $0.31MN/A
2022-07-05 13:17 ESTNewsHomology announces peer-reviewed preclinical data publication on its AAVHSC16 capsidN/A
2022-06-14 00:18 ESTNewsFDA lifts clinical hold on Homology Medicines' phenylketonuria trialN/A
2022-05-17 06:38 ESTNewsHomology Medicines GAAP EPS of $1.59 beats by $1.52N/A
2022-04-06 15:37 ESTNewsHomology stock falls 11% as Canaccord cuts price target citing potentially prolonged clinical holdN/A
2022-03-24 11:15 ESTNewsHomology Medicines GAAP EPS of -$0.59 beats by $0.02, revenue of $0.8M misses by $0.1MN/A
2022-03-11 11:09 ESTNewsOxford Biomedica completes deal with Homology Medicines to set up 1st US subsidiaryN/A
2022-02-23 00:19 ESTNewsHomology Medicines downgraded to perform at Oppenheimer on clinical holdN/A
2022-02-19 11:10 ESTNewsHomology Medicines sinks on FDA clinical hold for phenylketonuria trialN/A
2022-01-28 07:31 ESTNewsOxford Biomedica inks deal with Homology Medicines to expand viral vector offeringsN/A
2021-11-16 01:02 ESTNewsHomology Medicines EPS beats by $0.08, beats on revenueN/A
2021-10-22 07:34 ESTNewsHomology Medicines: In Vivo Gene Therapy Platform With Delayed Lead Trial Coming Back OnlineN/A
2021-10-18 13:16 ESTNewsHomology Medicines initiates early-stage HMI-203 Hunter syndrome trialN/A
2021-10-13 00:46 ESTNewsHomology Medicines to start clinical trial for gene editing candidate in phenylketonuriaN/A
2021-09-23 02:55 ESTNewsFIXX, DTIL, EAR and SYBX among after hours moversN/A
2021-08-12 17:04 ESTNewsHomology Medicines EPS beats by $0.06, beats on revenueN/A
2021-07-21 09:04 ESTNewsLMNL, CLAR, FIXX and PETS among after-hours moversN/A
2021-05-07 08:14 ESTNewsHomology Medicines EPS beats by $0.62, beats on revenueN/A
2021-04-06 20:50 ESTNewsHomology Medicines proposes $50M capital raiseN/A
2021-03-12 11:37 ESTEarnings EstimateAn EPS average of -$2.35 is estimated for the 2022 year.Sell
2021-03-12 11:37 ESTEarnings EstimateAn EPS average of -$0.70 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-12 07:41 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 07:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $28.44 to $27.Neutral
2021-01-18 03:39 ESTAnalyst RatingThe Analyst Target Price has decreased from $29 to $28.44.Neutral
2021-01-06 20:35 ESTNewsHomology Medicines unveils plans to start three gene therapy programs this yearN/A
2020-12-22 19:59 ESTNewsHomology Medicines: $60 Million Pfizer Equity-Investment, 4 Encouraging Candidates, And Competent ManagementN/A
2020-11-26 20:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 11:51 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 11:51 ESTEarnings EstimateAn EPS average of -$0.76 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-11 11:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $29.56 to $29.Neutral
2020-11-10 13:40 ESTNewsHomology Medicines nabs investment from PfizerN/A
2020-11-10 13:39 ESTNewsHomology Medicines EPS beats by $0.18, beats on revenueN/A
2020-11-07 15:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 08:18 ESTNewsHomology Medicines slumps on gene therapy data in inherited metabolic disorderN/A
2020-10-22 22:54 ESTNewsHomology Medicines unveils gene therapy program for rare metabolic disorderN/A
2020-10-07 17:49 ESTNewsHomology Medicines (FIXX) Investor Presentation - SlideshowN/A
2020-10-07 08:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $30.22 to $29.56.Neutral
2020-09-26 12:46 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:54 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 00:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $31 to $30.22.Neutral
2020-08-14 08:49 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 04:47 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 04:47 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.22 to $31.Neutral
2020-08-11 13:58 ESTNewsHomology Medicines EPS misses by $0.02, revenue in-lineN/A
2020-07-31 01:00 ESTFinancialsCompany financials have been released.Neutral

About Homology Medicines, Inc (FIXX):

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase I/II pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II. Homology Medicines, Inc. was incorporated in 2015 and is based in Bedford, Massachusetts.

FIXX Quotes by TradingView

See Advanced Chart

General

  • Name Homology Medicines, Inc
  • Symbol FIXX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 205
  • Fiscal Year EndDecember
  • IPO Date2018-03-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.homologymedicines.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 174.16
  • Price/Book (Most Recent Quarter) 2.64
  • Enterprise Value Revenue 116.77
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.70
  • Next Year EPS Estimate -$2.60
  • Next Quarter EPS Estimate -$0.67
  • Operating Margin -4821%
  • Return on Assets -28%
  • Return on Equity -57%
  • Revenue 2.7 million
  • Earnings Per Share -$2.18
  • Revenue Per Share $0.06
  • Gross Profit -97690000
  • Quarterly Earnings Growth 74.1%
View More

Highlights

  • Market Capitalization 509.92 million
  • EBITDA -86802000
  • PE Ratio -0.48
  • Analyst Target Price $27
  • Book Value Per Share $3.90
View More

Share Statistics

  • Shares Outstanding 50.49 million
  • Shares Float 29.56 million
  • % Held by Insiders 1645%
  • % Held by Institutions 89.82%
  • Shares Short 2.03 million
  • Shares Short Prior Month 2.09 million
  • Short Ratio 5.46
  • Short % of Float 6%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta -0.29
  • 52 Week High $19.4
  • 52 Week Low $8.82
  • 50 Day Moving Average 11.79
  • 200 Day Moving Average 11.21
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Homology Medicines, Inc (FIXX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Homology Medicines, Inc (FIXX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$980000-$0.62-$0.655.24%
2020-09-302020-11-09$N/A-$0.62-$0.8022.22%
2020-06-302020-08-10$N/A-$0.78-$0.76-2.79%
2020-03-312020-05-07$588000-$0.78-$0.66-18.18%
2019-12-312020-03-12$563000-$0.55-$0.6819.51%
2019-09-302019-11-12$441000-$0.67-$0.59-13.18%
2019-06-302019-08-08$392000-$0.61-$0.55-10.91%
2019-03-312019-05-13$270000-$0.64-$0.54-18.52%
2018-12-312019-03-12$980002-$0.52-$0.44-18.18%
2018-09-302018-11-13$954149-$0.40-$0.36-12.14%
2018-06-302018-08-13$926477-$0.35-$0.32-9.38%
2018-03-312018-05-14$823372-$4.21-$2.84-48.24%

Homology Medicines, Inc (FIXX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Homology Medicines, Inc (FIXX) Chart:

Homology Medicines, Inc (FIXX) News:

Below you will find a list of latest news for Homology Medicines, Inc (FIXX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Homology Medicines, Inc (FIXX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2030-12-18102.2CALL14 5100FALSE0.450.26
2030-12-1851.55PUT1 20TRUE0.120.08

Latest FIXX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.935
Jun 13, 2022 7:59 PM EST4$1.935
Jun 13, 2022 7:59 PM EST1$1.935
Jun 13, 2022 7:59 PM EST9$1.935
Jun 13, 2022 7:59 PM EST391$1.935

Homology Medicines, Inc (FIXX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016398/0000899243-20-016398-index.htm
2019-04-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1661998/000000000019006752/0000000000-19-006752-index.htm
2020-01-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000001961720000098/0000019617-20-000098-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000008025520001321/0000080255-20-001321-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000031506619001101/0000315066-19-001101-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000031506620001042/0000315066-20-001042-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009444/0000899243-18-009444-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009445/0000899243-18-009445-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009446/0000899243-18-009446-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009447/0000899243-18-009447-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009459/0000899243-18-009459-index.htm
2018-04-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318009495/0000899243-18-009495-index.htm
2018-05-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318013061/0000899243-18-013061-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318025449/0000899243-18-025449-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318031340/0000899243-18-031340-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318031342/0000899243-18-031342-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318031344/0000899243-18-031344-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924318031346/0000899243-18-031346-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319015642/0000899243-19-015642-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319015645/0000899243-19-015645-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319015647/0000899243-19-015647-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319015650/0000899243-19-015650-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016221/0000899243-19-016221-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016223/0000899243-19-016223-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016224/0000899243-19-016224-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016226/0000899243-19-016226-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016227/0000899243-19-016227-index.htm
2019-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016228/0000899243-19-016228-index.htm
2019-06-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319016520/0000899243-19-016520-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019172/0000899243-19-019172-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019474/0000899243-19-019474-index.htm
2019-07-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019624/0000899243-19-019624-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319019625/0000899243-19-019625-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319020990/0000899243-19-020990-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319020993/0000899243-19-020993-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319022839/0000899243-19-022839-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319022840/0000899243-19-022840-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319023114/0000899243-19-023114-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm
2019-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm
2019-12-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319028396/0000899243-19-028396-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319028397/0000899243-19-028397-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319029153/0000899243-19-029153-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319029154/0000899243-19-029154-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319029156/0000899243-19-029156-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319029157/0000899243-19-029157-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924319029158/0000899243-19-029158-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320000314/0000899243-20-000314-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320000316/0000899243-20-000316-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320002311/0000899243-20-002311-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320003246/0000899243-20-003246-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320008885/0000899243-20-008885-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016388/0000899243-20-016388-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016390/0000899243-20-016390-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016391/0000899243-20-016391-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016392/0000899243-20-016392-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016395/0000899243-20-016395-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320016398/0000899243-20-016398-index.htm
2020-07-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320019812/0000899243-20-019812-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000089924320019813/0000899243-20-019813-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000101297519000390/0001012975-19-000390-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000107261319000105/0001072613-19-000105-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000107261320000098/0001072613-20-000098-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918022462/0001104659-18-022462-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm
2018-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm
2019-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000110465919005517/0001104659-19-005517-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000110465919007932/0001104659-19-007932-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000110465920011469/0001104659-20-011469-index.htm
2020-03-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000110465920031227/0001104659-20-031227-index.htm
2018-04-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000119312518114234/0001193125-18-114234-index.htm
2019-04-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1661998/000119312519094628/0001193125-19-094628-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519094758/0001193125-19-094758-index.htm
2019-04-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1661998/000119312519100527/0001193125-19-100527-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519100789/0001193125-19-100789-index.htm
2019-04-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661998/000119312519100794/0001193125-19-100794-index.htm
2019-04-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1661998/000119312519102942/0001193125-19-102942-index.htm
2019-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519103880/0001193125-19-103880-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661998/000119312519119853/0001193125-19-119853-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1661998/000119312519119871/0001193125-19-119871-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519169173/0001193125-19-169173-index.htm
2019-06-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519184386/0001193125-19-184386-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519194114/0001193125-19-194114-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312519318478/0001193125-19-318478-index.htm
2020-03-12S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1661998/000119312520071690/0001193125-20-071690-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312520166769/0001193125-20-166769-index.htm
2020-07-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1661998/000119312520196449/0001193125-20-196449-index.htm
2018-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm
2018-04-06SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661998/000119380518000516/0001193805-18-000516-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380519000360/0001193805-19-000360-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380519000567/0001193805-19-000567-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm
2019-12-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661998/000119380519001984/0001193805-19-001984-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm
2020-01-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661998/000119380520000088/0001193805-20-000088-index.htm
2020-04-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661998/000119380520000496/0001193805-20-000496-index.htm
2020-05-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1661998/000119380520000541/0001193805-20-000541-index.htm
2019-12-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000149315219019826/0001493152-19-019826-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000149315220002397/0001493152-20-002397-index.htm
2018-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459018013403/0001564590-18-013403-index.htm
2018-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459018021456/0001564590-18-021456-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459018029297/0001564590-18-029297-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661998/000156459019007250/0001564590-19-007250-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459019018819/0001564590-19-018819-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459019030748/0001564590-19-030748-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459019042892/0001564590-19-042892-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1661998/000156459020010441/0001564590-20-010441-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1661998/000156459020019187/0001564590-20-019187-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1661998/000156459020019197/0001564590-20-019197-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459020022819/0001564590-20-022819-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1661998/000156459020038900/0001564590-20-038900-index.htm
2019-01-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1661998/000156761919000962/0001567619-19-000962-index.htm
2019-04-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1661998/999999999519000651/9999999995-19-000651-index.htm

Homology Medicines, Inc (FIXX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Homology Medicines, Inc (FIXX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1645%
Institutional Ownership: 8982%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-01-30James E Flynn10% Share HolderSell509,970.0015.457,879,036.500.00https://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm
2019-06-03Timothy P KellyOfficerSell1,288.0020.0025,764.890.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015650/0000899243-19-015650-index.htm
2019-09-05Timothy P KellyOfficerSell1,166.0019.9423,251.440.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319023114/0000899243-19-023114-index.htm
2020-03-17Timothy P KellyOfficerSell1,315.0013.0117,108.540.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320008885/0000899243-20-008885-index.htm
2019-06-03W Bradford SmithCFO, Treasurer & SecretarySell6,000.0019.94119,664.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm
2019-07-01W Bradford SmithCFO, Treasurer & SecretarySell6,000.0019.00113,971.200.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm
2019-08-01W Bradford SmithCFO, Treasurer & SecretarySell6,000.0017.37104,190.600.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm
2019-09-03W Bradford SmithCFO, Treasurer & SecretarySell6,000.0018.74112,419.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm
2019-10-01W Bradford SmithCFO, Treasurer & SecretarySell100.0018.231,823.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm
2019-11-29W Bradford SmithCFO, Treasurer & SecretarySell6,000.0016.0096,000.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm
2019-12-02W Bradford SmithCFO, Treasurer & SecretarySell6,000.0016.2197,266.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm
2020-01-02W Bradford SmithCFO, Treasurer & SecretarySell6,000.0020.50122,984.400.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm
2020-02-03W Bradford SmithCFO, Treasurer & SecretarySell12,000.0016.16193,866.000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm
2019-10-01W Bradford SmithCFO, Treasurer & SecretarySell5,900.0017.38102,543.77100.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm
2019-12-02ARTHUR TZIANABOSPresident & CEOSell12,500.0016.25203,176.25102,505.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm
2019-11-18Richard J. GregoryDirectorBuy10,806.000.03324.1810,806.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320002311/0000899243-20-002311-index.htm
2019-11-29ARTHUR TZIANABOSPresident & CEOSell12,500.0016.04200,558.75115,005.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028394/0000899243-19-028394-index.htm
2019-04-12James E FlynnDirectorBuy533,333.0022.5011,999,992.501,158,333.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519000360/0001193805-19-000360-index.htm
2018-04-02MAHENDRA SHAHDirectorBuy500,000.0016.008,000,000.001,159,742.00https://www.sec.gov/Archives/edgar/data/1661998/000089924318009459/0000899243-18-009459-index.htm
2020-02-03W Bradford SmithCFO, Treasurer & SecretaryBuy12,000.000.637,579.2012,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320003248/0000899243-20-003248-index.htm
2019-10-01ARTHUR TZIANABOSPresident & CEOSell100.0018.231,823.00127,505.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm
2019-10-01ARTHUR TZIANABOSPresident & CEOSell12,400.0017.39215,644.68127,605.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024657/0000899243-19-024657-index.htm
2019-09-03ARTHUR TZIANABOSPresident & CEOSell12,500.0018.75234,320.00140,005.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319022839/0000899243-19-022839-index.htm
2019-08-01ARTHUR TZIANABOSPresident & CEOSell12,500.0017.37217,111.25152,505.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319020990/0000899243-19-020990-index.htm
2020-01-02Albert SeymourChief Scientific OfficerSell9,133.0020.50187,216.45154,017.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320000314/0000899243-20-000314-index.htm
2019-12-02Albert SeymourChief Scientific OfficerSell9,300.0016.23150,969.69163,150.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm
2019-07-01ARTHUR TZIANABOSPresident & CEOSell12,500.0018.98237,300.00165,005.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019172/0000899243-19-019172-index.htm
2019-11-29Albert SeymourChief Scientific OfficerSell9,300.0016.06149,389.62172,450.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028392/0000899243-19-028392-index.htm
2019-12-24James E Flynn10% Share HolderSell151,233.0021.953,319,579.471,766,106.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm
2019-06-03ARTHUR TZIANABOSPresident & CEOSell12,500.0019.86248,262.50177,505.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015645/0000899243-19-015645-index.htm
2019-10-01Albert SeymourChief Scientific OfficerSell100.0018.231,823.00181,750.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm
2019-10-01Albert SeymourChief Scientific OfficerSell9,200.0017.38159,936.48181,850.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024656/0000899243-19-024656-index.htm
2019-09-03Albert SeymourChief Scientific OfficerSell9,300.0018.74174,283.86191,050.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319022840/0000899243-19-022840-index.htm
2019-12-23James E Flynn10% Share HolderSell56,595.0021.831,235,434.891,917,339.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-12-20James E Flynn10% Share HolderSell9,130.0021.50196,296.831,973,934.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-12-19James E Flynn10% Share HolderSell5,454.0021.68118,218.721,983,064.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-08-01Albert SeymourChief Scientific OfficerSell9,300.0017.37161,523.33200,350.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319020993/0000899243-19-020993-index.htm
2019-07-01Albert SeymourChief Scientific OfficerSell100.0019.561,956.00209,650.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm
2019-07-01Albert SeymourChief Scientific OfficerSell9,200.0018.98174,582.88209,750.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019182/0000899243-19-019182-index.htm
2019-06-03Albert SeymourChief Scientific OfficerSell9,300.0019.90185,093.25218,950.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015647/0000899243-19-015647-index.htm
2019-05-165AM Ventures IV, L.P.10% Share HolderSell24,600.0021.47528,162.00221,435.00https://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm
2019-05-16KUSH PARMARDirectorSell24,600.0021.47528,162.00221,435.00https://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm
2019-07-09Siyamak RastyChief Operating OfficerSell8,000.0020.00160,000.00222,707.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019474/0000899243-19-019474-index.htm
2019-06-03Siyamak RastyChief Operating OfficerSell8,000.0020.22161,777.60230,707.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015642/0000899243-19-015642-index.htm
2019-12-24James E Flynn10% Share HolderSell198,767.0021.954,362,955.532,321,199.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001981/0001193805-19-001981-index.htm
2018-12-105AM Ventures IV, L.P.10% Share HolderSell623.0026.0116,201.18246,035.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm
2018-12-10KUSH PARMARDirectorSell623.0026.0116,201.18246,035.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm
2018-11-235AM Ventures IV, L.P.10% Share HolderSell1,187.0020.0423,782.73246,658.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm
2018-11-23KUSH PARMARDirectorSell1,187.0020.0423,782.73246,658.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm
2018-11-165AM Ventures IV, L.P.10% Share HolderSell21,036.0020.20424,927.20247,845.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm
2018-11-16KUSH PARMARDirectorSell21,036.0020.20424,927.20247,845.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm
2019-12-23James E Flynn10% Share HolderSell74,384.0021.831,623,758.092,519,966.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-12-20James E Flynn10% Share HolderSell11,999.0021.50257,980.902,594,350.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2019-12-19James E Flynn10% Share HolderSell7,168.0021.68155,370.702,606,349.00https://www.sec.gov/Archives/edgar/data/1661998/000119380519001976/0001193805-19-001976-index.htm
2018-04-02James E FlynnDirectorBuy625,000.0016.0010,000,000.002,613,517.00https://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm
2020-01-29James E Flynn10% Share HolderSell8,857.0015.45136,807.88509,970.00https://www.sec.gov/Archives/edgar/data/1661998/000119380520000087/0001193805-20-000087-index.htm
2020-01-28James E Flynn10% Share HolderSell65,891.0015.511,021,936.46518,827.00https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm
2019-05-165AM Ventures IV, L.P.10% Share HolderSell590,400.0021.4712,675,888.005,314,484.00https://www.sec.gov/Archives/edgar/data/1661998/000110465919030566/0001104659-19-030566-index.htm
2019-05-16KUSH PARMARDirectorSell590,400.0021.4712,675,888.005,314,484.00https://www.sec.gov/Archives/edgar/data/1661998/000110465919030565/0001104659-19-030565-index.htm
2020-01-27James E Flynn10% Share HolderSell193,359.0015.773,049,600.14584,718.00https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm
2018-12-105AM Ventures IV, L.P.10% Share HolderSell14,952.0026.01388,828.265,904,884.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918072619/0001104659-18-072619-index.htm
2018-12-10KUSH PARMARDirectorSell14,952.0026.01388,828.265,904,884.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918072618/0001104659-18-072618-index.htm
2018-11-235AM Ventures IV, L.P.10% Share HolderSell28,495.0020.04570,925.825,919,836.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918070148/0001104659-18-070148-index.htm
2018-11-23KUSH PARMARDirectorSell28,495.0020.04570,925.825,919,836.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918070149/0001104659-18-070149-index.htm
2018-11-165AM Ventures IV, L.P.10% Share HolderSell504,864.0020.2010,198,252.805,948,331.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918069431/0001104659-18-069431-index.htm
2018-11-16KUSH PARMARDirectorSell504,864.0020.2010,198,252.805,948,331.00https://www.sec.gov/Archives/edgar/data/1661998/000110465918069432/0001104659-18-069432-index.htm
2019-06-03W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319015653/0000899243-19-015653-index.htm
2019-07-01W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319019175/0000899243-19-019175-index.htm
2019-08-01W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319020992/0000899243-19-020992-index.htm
2019-09-03W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319022841/0000899243-19-022841-index.htm
2019-10-01W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319024658/0000899243-19-024658-index.htm
2019-11-29W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm
2019-12-02W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.643,840.006,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924319028395/0000899243-19-028395-index.htm
2020-01-02W Bradford SmithCFO, Treasurer & SecretaryBuy6,000.000.633,789.606,000.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320000313/0000899243-20-000313-index.htm
2018-04-02James E FlynnDirectorBuy625,000.0016.0010,000,000.00625,000.00https://www.sec.gov/Archives/edgar/data/1661998/000119380518000506/0001193805-18-000506-index.htm
2020-02-03ARTHUR TZIANABOSPresident & CEOSell12,500.0016.16202,021.2577,505.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320003246/0000899243-20-003246-index.htm
2020-01-24James E Flynn10% Share HolderSell380,256.0015.695,964,999.82778,077.00https://www.sec.gov/Archives/edgar/data/1661998/000119380520000076/0001193805-20-000076-index.htm
2020-01-02ARTHUR TZIANABOSPresident & CEOSell12,500.0020.50256,191.2590,005.00https://www.sec.gov/Archives/edgar/data/1661998/000089924320000316/0000899243-20-000316-index.htm